T Cell Count

Measures the integrity of the immune system at the cellular level to help identify a patient’s immune status and immunotype(s), based on 28 key biomarkers and determinants. The Lymphocyte MAP™ is an innovative new test that establishes a new standard in screening the immune system. As the best measurement of immune health, it classifies different lymphocytes beyond the ordinary testing of lymphocyte subpopulations. It includes not only T and B cells and CD4/CD8 ratios, but also the very important Th1, Th2, Treg (regulatory T cells), and Th17 cells and their ratios, as well as a variety of natural killer (NK) cells such as CD56+, CD16+, CD56+ D16+, CD57+, CD57+CD8+, CD57+CD16+ (known as the superkillers), and the immunoregulatory NKT cells. Detects overall immune health of individuals and disorders associated with infections, cancers, allergies/hypersensitivities, mast cell activation, and autoimmunities. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2004, 2006, 2011, and 2024.

Measures the integrity of the immune system at the cellular level to help identify a patient’s immune status and immunotype(s), based on 28 key biomarkers and determinants. The Lymphocyte MAP™ is an innovative new test that establishes a new standard in screening the immune system. As the best measurement of immune health, it classifies different lymphocytes beyond the ordinary testing of lymphocyte subpopulations. It includes not only T and B cells and CD4/CD8 ratios, but also the very important Th1, Th2, Treg (regulatory T cells), and Th17 cells and their ratios, as well as a variety of natural killer (NK) cells such as CD56+, CD16+, CD56+ D16+, CD57+, CD57+CD8+, CD57+CD16+ (known as the superkillers), and the immunoregulatory NKT cells. Detects overall immune health of individuals and disorders associated with infections, cancers, allergies/hypersensitivities, mast cell activation, and autoimmunities. Developed and published by Aristo Vojdani, PhD, MSc, CLS, known as the father of functional immunology, in 2004, 2006, 2011, and 2024.

The IgXSpot test is an enzyme–linked immunospot assay that detects human T cells reactive to Borrelia/pathogen–specific antigens in vitro. It is recommended for detection of very early and/or late Borrelia/pathogen infection and in seronegative patient’s whole blood samples. When combined with Lyme ImmunoBlot tests, this test provides information on the full spectrum of a patient’s immune response to infection and stage of disease. This test is unavailable for patients over 65 when ordered through physician services.

The Bartonella IgXSpot test is an Enzyme–Linked ImmunoSpot (ELISPOT) assay that detects human T cells reactive to Bartonella specific antigens in vitro, including B. henselae, B. quintana, B. elizabethae, and B. vinsonii. It detects specific T cell responses soon after Bartonella infection or late in the disease. This test is unavailable for patients over 65 when ordered through physician services.

This panel is designed to detect Bartonellosis. It combines 3 tests: Bartonella ImmunoBlot IgM, Bartonella ImmunoBlot IgG, and Bartonella IgXSpot. This test is unavailable for patients over 65 when ordered through physician services.